The Society for Laboratory Automation and Screening (SLAS) is expanding its Innovation AveNEW exhibition programme to include venues and events in Spain, Berlin, London and Boston in order to provide more opportunities for laboratory technology and automation startups to get the recognition and attention they need to succeed. Applications are now open. … Read More
The National Institutes of Health (NIH) has awarded approximately $53 million in annual funding over the next five years to ten research organisations in a continued effort to find a cure for HIV. The new awards for the Martin Delaney Collaboratories for HIV Cure Research programme expand the initiative’s 2016 renewal from six institutions to ten. Read More
Dotmatics, a scientific informatics software and services company, has been selected by Croda International to implement its research and development (R&D) digital program. This project will reportedly deepen Croda’s ability to innovate collaboratively, both internally and externally, delivering enhanced data science capability across the company’s global R&D… Read More
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a new indication for GW Pharmaceutical’s cannabidiol as an adjunctive treatment of seizures associated with tuberous sclerosis complex (TSC), for patients two years of age and older. GW was initially granted marketing authorisation for this medicine in the UK in September 2019 as an… Read More
BridgeBio Pharma has entered a clinical collaboration with Bristol Myers Squibb to evaluate the combination of BBP-398, a potentially best-in-class SHP2 inhibitor, with OPDIVO (nivolumab) in patients with advanced solid tumours with KRAS mutations with the hope of providing an effective new treatment option for patients with difficult-to-treat cancers. The… Read More
CureVac and GSK have published preclinical data investigating immune responses as well as the protective efficacy of CureVac’s first-generation vaccine candidate, CVnCoV, and second-generation vaccine candidate, CV2CoV, against SARS-CoV-2 challenge in non-human primates. The study, conducted in collaboration with Harvard Medical School, assessed cynomolgus macaques vaccinated… Read More
This is the latest episode of the free DDW podcast, “Streamlining gene therapy manufacturing and how MS provides information on virus structure”. It covers two narrated articles written for DDW and is read aloud by Megan Thomas, both of which were published in Volume 22, Issue 1 – Winter 2020/21… Read More
In this podcast, Megan Thomas narrated two articles in which Akash Bhattacharya, the Senior Application Scientist at Beckman Coulter Life Sciences, explains how streamlining gene therapy manufacturing will help products reach more patients, and Andreas Huhmer, Senior Director of Proteomics and Metabolomics at Thermo Fisher Scientific, discusses the value of… Read More
The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology’s Elenagen, an experimental DNA therapy, to include hormone-resistant breast cancer and hormone-resistant metastatic prostate cancer. The decision to add two more deadly diseases to the ongoing study was based on encouraging preliminary results… Read More
CN Bio has licenced a novel tool for modelling the gut microbiome, GuMI, from Massachusetts Institute of Technology (MIT) and Northeastern University to investigate the direct interaction between the microbiome and gut and the wider effects of the microbiome on organs such as the liver and brain. Planned for commercial… Read More
Angelini Pharma and Lumira have launched the Angelini Lumira Biosciences Fund (ALBF), which has been established to invest in early-stage companies in Canada and U.S. markets that are developing pharmaceutical therapies for central nervous system disorders (CNS) and rare diseases. The ALBF will be managed by Lumira Ventures and Angelini… Read More
Abzena and BioXpress Therapeutics have partnered to support biosimilar development for third party customers, creating an integrated solution between two service providers with expertise in biosimilar development and GMP manufacture. The partnership will ensure biosimilar drug developers benefit from an integrated approach to biosimilars spanning the range from design consultancy,… Read More
OGT has expanded its activities with CytoCell University, an initiative that provides training to scientists on the basics of fluorescence in situ hybridisation (FISH). CytoCell University’s FISH training and OGT aim to support scientists internationally and help customers advance genetic analysis. CytoCell University’s first module, set to be part of… Read More
UCB, a biopharmaceutical company, has presented new interim data from BE BRIGHT, an open-label extension (OLE) trial of an interleukin (IL)-17A/F inhibitor ‘bimekizumab’ for plaque psoriasis (PsO), at the 2021 American Academy of Dermatology (AAD) Summer Meeting. While the data are still preliminary, they strongly support a potential approval for… Read More
Beckley Psytech has completed Series B financing, raising $80 million from venture capital (VC) investors to fund its research programmes. The financing was initially set at $50 million and was upsized to $80 million due to interest from investors in broadening and accelerating the clinical development of Beckley Psytech’s research… Read More
Listen to this article on the DDW Podcast: An expert’s view by John Yoshi Shyu, Ph.D. Corning Life Sciences. Most vaccines are manufactured using technology devised fifty or more years ago, in manufacturing plants that are sometimes even older. The vaccine production process is continually refreshed by new tools and technologies,… Read More
